TA200 Hepatitis C - peginterferon alfa and ribavirin: Appendix A - decision paper presented to the Institute's Guidance Executive
TA200 Hepatitis C - peginterferon alfa and ribavirin: Appendix A - decision paper presented to the Institute's Guidance Executive
20 December 2013 (111.64 Kb 32 sec) |
This page was last updated: 18 December 2013